For men with prostate cancer, radiation seed implants may yield a better short-term side effect profile than surgery, but surgery may offer slightly better long-term outcomes, new research from French radiation oncologists indicates.
For men with prostate cancer, radiation seed implants may yield a better short-term side effect profile than surgery, but surgery may offer slightly better long-term outcomes, new research from French radiation oncologists indicates. The results were published in the International Journal for Radiation Oncology*Biology*Physics (2007; 67:812-22).
This comparative study of 435 men with early-stage prostate cancer measured male quality of life, treatment-specific side effects, and cost of treatment based on the type of treatment used: prostate brachytherapy or radical prostatectomy. Men were surveyed before and immediately after treatment, as well as at designated follow-up periods. Data were obtained from 11 French hospitals.
The findings indicated that surgery produced more immediate and significant side effects post-treatment, but those side effects subsided and actually improved after 2 years. With brachytherapy, although patients saw consistently moderate side effects, the side effects persisted over time. For those who received surgery, urinary incontinence and impaired sexual function were common side effects. Urinary irritation was more common in those receiving brachytherapy.
Although brachytherapy may cost more initially, follow-up costs associated with surgery balance out the initial expense of brachytherapy, according to co-author Jean-Marc Cosset, MD, of the Institut Curie in Paris.
Brachytherapy offers high 8-year prostate Ca survival rates
February 15th 2007More than 90% of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of the disease 8 years after diagnosis, according to a recent study in the International Journal for Radiation Oncology Biology Physics (2007; 67:327-33).
Research on bladder tissue regeneration progresses
February 1st 2007Atlanta-Tissue engineering research has grown by leaps and bounds in the past decade and a half, yielding findings that may someday have a profound impact on the field of pediatric urology. At the 2006 American Academy of Pediatrics Section on Urology annual meeting here, several groups presented cutting-edge data on novel systems for organ generation, including research demonstrating the feasibility of generating a functioning bladder from stem cells.
Radiation therapy combination prolongs long-term cure rate in men with PCa
January 18th 2007Three-fourths of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study published in the International Journal of Radiation Oncology*Biology*Physics (2007; 67:57-64).
Cystectomy outcomes: Does surgeon's age matter?
October 1st 2006Ann Arbor, MI-Surgeon age is not a significant predictor of risk of mortality after cystectomy, according to the results of a recently published study from researchers at the University of Michigan, Ann Arbor (Ann Surg 2006; 244:353-62).